Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates.
Kwon
Yong-Dae
YD
Kim
Deog-Yoon
DY
D050071:Bone Density Conservation Agents / Q000009:adverse effects; D024042:Collagen Type I / Q000097:blood*; D006801:Humans; D007571:Jaw Diseases / Q000097:blood* / Q000139:chemically induced / Q000473:pathology*; D010020:Osteonecrosis / Q000097:blood* / Q000139:chemically induced / Q000473:pathology*; D010455:Peptides / Q000097:blood*; D012107:Research Design; D018570:Risk Assessment / Q000379:methods
D050071:Bone Density Conservation Agents; D024042:Collagen Type I; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide